Table I Index
Table of Contents
|
Table I - 79 Tippecanoe Incidence Rate1 by Primary Site and Sex: Cases Diagnosed in 1996, Indiana |
||||||
Primary Site |
Total |
Males | Females | |||
| Number | Rate | Number | Rate | Number | Rate | |
| All sites | 429 | 342.4 | 198 | 365.3 | 231 | 333.1 |
| Oral cavity and pharynx | 8 | 6.3** | 8 | 14.3** | * | # |
| Lip | * | # | * | # | * | # |
| Tongue | * | # | * | # | * | # |
| Major salivary glands | * | # | * | # | * | # |
| Floor of mouth | * | # | * | # | * | # |
| Gum and other mouth | * | # | * | # | * | # |
| Nasopharynx | * | # | * | # | * | # |
| Tonsil | * | # | * | # | * | # |
| Oropharynx | * | # | * | # | * | # |
| Hypopharynx | * | # | * | # | * | # |
| Pharynx and other oral cavity | * | # | * | # | * | # |
| Digestive system | 69 | 56.7 | 32 | 61.3 | 37 | 52.6 |
| Esophagus | 6 | 4.8** | 5 | 9.8** | * | # |
| Stomach | * | # | * | # | * | # |
| Small intestine | * | # | * | # | * | # |
| Colon excluding rectum | 37 | 30.7 | 14 | 27.0** | 23 | 33.3 |
| Rectum and rectosigmoid | 11 | 9.0** | 6 | 11.2** | 5 | 7.2** |
| Anus, anal canal, and anorectum | * | # | * | # | * | # |
| Liver and intrahepatic bile duct | * | # | * | # | * | # |
| Gallbladder | * | # | * | # | * | # |
| Other biliary | * | # | * | # | * | # |
| Pancreas | 6 | 5.0** | * | # | * | # |
| Retroperitoneum | * | # | * | # | * | # |
| Peritoneum | * | # | * | # | * | # |
| Other digestive organs | * | # | * | # | * | # |
| Respiratory system | 77 | 64.8 | 47 | 89.5 | 30 | 46.9 |
| Nasal cavity, ear, and sinuses | * | # | * | # | * | # |
| Larynx | * | # | * | # | * | # |
| Lung and bronchus | 72 | 60.1 | 42 | 79.2 | 30 | 46.9 |
| Trachea, pleura, and other respiratory organs | * | # | * | # | * | # |
| Bones and joints | * | # | * | # | * | # |
| Soft tissue (including heart) | * | # | * | # | * | # |
| Skin (excluding basal and squamous) | 16 | 11.6** | 8 | 14.7** | 8 | 10.0** |
| Melanoma of the skin | 16 | 11.6** | 8 | 14.7** | 8 | 10.0** |
| Other non-epithelial skin cancers | * | # | * | # | * | # |
| Breast | 74 | 58.9 | * | # | 74 | 107.6 |
| Female genital system | 33 | 27.2 | -- | -- | 33 | 50.0 |
| Cervix uteri | * | # | -- | -- | * | # |
| Corpus uteri | 18 | 15.3** | -- | -- | 18 | 27.7** |
| Uterus, NOS | * | # | -- | -- | * | # |
| Ovary | 8 | 6.8** | -- | -- | 8 | 12.9** |
| Vagina | * | # | -- | -- | * | # |
| Vulva | * | # | -- | -- | * | # |
| Other female genital organs | * | # | -- | -- | * | # |
| Male genital system | 53 | 43.9 | 53 | 97.4 | -- | -- |
| Prostate gland | 46 | 39.0 | 46 | 87.9 | -- | -- |
| Testis | 5 | 2.5** | 5 | 4.7** | -- | -- |
| Penis | * | # | * | # | -- | -- |
| Other male genital organs | * | # | * | # | -- | -- |
| Urinary system | 30 | 21.8 | 21 | 38.5 | 9 | 11.7** |
| Urinary bladder | 22 | 15.6 | 16 | 30.0** | 6 | 7.2** |
| Kidney and renal pelvis | 8 | 6.2** | 5 | 8.6** | * | # |
| Ureter | * | # | * | # | * | # |
| Other urinary organs | * | # | * | # | * | # |
| Eye and orbit | * | # | * | # | * | # |
| Brain and other nervous system | 6 | 5.6** | * | # | * | # |
| Brain | 6 | 5.6** | * | # | * | # |
| Other nervous system | * | # | * | # | * | # |
| Endocrine system | * | # | * | # | * | # |
| Thyroid gland | * | # | * | # | * | # |
| Other endocrine (including thymus) | * | # | * | # | * | # |
| Lymphoma | 27 | 20.1 | 6 | 8.9** | 21 | 29.7 |
| Hodgkin’s disease | * | # | * | # | * | # |
| Non-Hodgkin’s lymphoma | 24 | 17.9 | 5 | 7.7** | 19 | 26.6** |
| Multiple myeloma | 7 | 4.2** | * | # | * | # |
| Leukemia | 10 | 6.9** | 7 | 11.0** | * | # |
| Acute lymphocytic | * | # | * | # | * | # |
| Chronic lymphocytic | * | # | * | # | * | # |
| Acute myeloid | * | # | * | # | * | # |
| Chronic myeloid | * | # | * | # | * | # |
| Other leukemias | * | # | * | # | * | # |
| Other, ill-defined and unknown sites | 14 | 11.4** | 7 | 13.8** | 7 | 10.6** |
1 Per 100,000; Age-adjusted, 1970 U.S. Standard Million. Excludes in situ cancers except bladder, and also excludes basal and squamous cell carcinomas of the skin. * Fewer than 5 cases, number suppressed to protect confidentiality. ** Rates based on fewer than twenty cases are unstable. # Rate cannot be calculated. _______________________________________________________________ Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, January 2001 |
||||||